I think they have good regulatory compliance record and mainly have OTC products. Their Formulations are sold in highly regulated market and that speaks for the quality. I think they are growing well. I think they are likely to double the revenue in less than 4 years. With margins increasing because of economies of scale as well as operating leverage I think their profits are likely to grow faster than revenue. Management looks capable and are very careful of what they say about the future.
Disclosed. Invested
Subscribe To Our Free Newsletter |